Gallafent patent opposition analysis

The comprehensive analysis of Gallafent opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Gallafent

Patent NumberTitleApplicantOpposition DateOpposition Company
Combinations Comprising Mtor Inhibitors For Treating CancerNOVARTISJun 17, 2015GENERICS UK TRADING MYLAN
Dosage Regimen Of An S1P Receptor AgonistNOVARTISApr 1, 2015GENERICS UK TRADING MYLAN

Top companies who are the clients of Gallafent